Browse products
Clinical trials in Russia 2008Russia compared to other countries |
Our clients say...
Based on a comprehensive survey carried out on the management staff from almost fifty companies, Clinical trials in Russia 2008 offers an extensive overview of Russia’s clinical trials market in the context of other Central and Eastern European countries. Its exhaustive analysis of current and prospective market trends and a detailed discussion of the market’s legal aspects, provide an all-embracing picture of the sector.
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
As a supplement, the report offers a directory of Contract Research Organisations and pharmaceutical companies active in clinical trials in Russia.
This report is essential reading for:
- the senior management of companies active on the clinical trials market
- clinical Research Organisations and pharmaceutical companies interested in launching operations in Russia or cooperating with their Russian counterparts
- companies interested in providing medical products and equipment for the clinical trials market in Russia
- pharmaceutical companies and CROs keen to keep track of Russia’s rapidly growing clinical trials market
- decision makers who, for professional reasons, need to gain a thorough understanding of the key trends on the market.
Request sample pages/interactive screenshare
-
Report methodology
-
Executive summary
-
Background
-
Overview of the Russian clinical trials market
- Size of the clinical trials market in Russia in 1997-2007
- Structure of the clinical trials market
- Number of trials and patients participating in trials, with forecasts for 2008-2012
- Patient recruitment
- Infrastructure of clinical trials
- Major events and trends on the clinical research market in Russia
- Current events and trends
- Anticipated trends
-
Largest companies conducting clinical research in Russia in 2006 and 2007
- Largest international sponsors in Russia
- Largest national sponsors in Russia
- Workforce size and characteristics
- Number of patients participating in trials
- Main areas of interest of companies conducting clinical trials in Russia
- Phases of clinical trials conducted in 2007
- Foreign operations of local firms
-
Results of survey among companies conducting clinical research in Russia
- Introduction
- Evaluation of situation in Russian clinical research market
- Assessment of current market situation
- Forecasts of market situation in 2008
- Opportunities and barriers to business development in the clinical trials market in Russia
- Key barriers to business development
- Pros and cons of regionalisation of clinical trials in Moscow and other regions
- Key factors conducive to development of operations
- Market development expectations in the years 2008-2009
- Time required to register clinical trials in Russia
- Assessment of financial situation
- Foreign operations
- Comparative analysis of the clinical research environment in Russia and selected other countries
-
Legal aspects of clinical research
- Most important institutions on clinical research market in Russia
- Major legislation regulating clinical trials in Russia
- Approval for conducting clinical trials in Russia
- Principles of Good Clinical Practice
- Procedures connected with the work of ethics committees
- Occurrence of side effects and adverse events during clinical trials
- Inspection of clinical trials
- National inspections
- FDA inspections
- Imports of medicinal products for use in clinical trials
- Insuring clinical trials
- Tax on clinical trials
- Contracts in clinical trials
- Fees in clinical trials
- Laboratory and diagnostic services
-
Attitudes to clinical trials in Russia
- General attitudes towards clinical trials
- Effectiveness of recruitment tools
- Physicians' attitudes
- Officials' attitudes
-
Basic demographic facts
- Russia’s population and its density
- Prevalence of illnesses in Russia
List of graphs
- Number of international clinical trials in Russia, 1992-2007
- Relative increase of the number of clinical trial in Russia, 1992-2007
- Structure of trials in Russia, 2004-2007
- Proportion of randomised and blind trials in trials sponsored by local and international companies in Russia, Q3 2007
- Russian research centres most involved in clinical trials (number of sites), 2007
- Number of clinical trials in Russia, 1997-2012
- Patient recruitment effectiveness in selected CEE countries (number of patients per site), 2007
- Number of clinical trials approved by RZN in Russia, Q1 2006-Q4 2007
- Numbers of all, international, and local clinical trials approved in Russia, Q1 2006-Q4 2007
- The largest international sponsors of trials (by number of trials approved) in Russia, 2006 and 2007
- The largest international sponsors of trials (by number of trials approved) in Russia, 2000-April 2007
- Distribution of sponsors’ countries of origin on the Russian clinical trials market, Q4 2007
- The largest local sponsors of trials (by number of trials approved) in Russia, 2007
- The largest local sponsors of trials (by number of trials approved) in Russia, 2006
- The largest international sponsors of trials (by number of patients involved in new trials) in Russia, 2007
- The largest local sponsors of trials (by number of patients involved in new trials) in Russia, 2007
- Main areas of interest of companies conducting clinical trials in Russia, by therapeutic area, 2004-2007
- Main areas of interest of companies conducting clinical trials in Russia, by phase of study, 2004-2007
- Assessment of current situation on clinical research market in Russia (no. of companies), December 2007
- Reasons for positive assessment of market situation in Russia (no. of companies), December 2007
- Will the situation in the clinical research sector in Russia deteriorate, improve or remain unchanged in 2008? (no. of companies), December 2007
- Why do you think the market situation will improve in 2008 in Russia? (no. of companies), December 2007
- Key barriers to business development on Russian clinical trials market (no. of companies), December 2007
- Comparison of distribution of costs in Moscow and regional sites in Russia, 2007
- Number of clinical sites in different regions in Russia, 2003-2006
- Main factors which could help your company grow in the coming years in Russia (no. of companies), December 2007
- Forecasts for the development of the Russian clinical research market in the years 2008-2009 (% of respondents), December 2007
- Time from protocol approval to FPFV* in selected countries (months), 2007
- Assessment of the current financial state of your clinical research firm in comparison to 2006 Russia (no. of companies), December 2007
- Forecast of your company’s financial situation in 2008 in Russia (no. of companies), December 2007
- Does your firm conduct clinical trials abroad? (% of respondents), December 2007
- Countries where companies present in Russia also conduct clinical trials (no. of companies), December 2007
- Delays in issue of permission for clinical trials in selected CEE countries and Russia, 2007
- Percentage of FDA inspections by region resulting in official action indicated (OAI)
- FDA inspections in selected CEE countries, 1977-2006
- Population of Russia (millions), 2001-2010
- Coefficient of mortality in Russia, 1950-2006
- Population by age and gender in Russia (’000), 2007
- Smoking prevalence (% of population) among adult males worldwide
List of tables
- Pros and cons of conducting clinical research in Moscow and other regions in Russia, 2007
- Comparative analysis of the conditions for conducting clinical trials in selected countries and in Russia, December 2007
Clinical trials in Russia 2008
Russia compared to other countries
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English | 1800€ | 2700€ | 3600€ | 4500€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.